Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 347,121 | 152,822 | 218,779 | 77,922 | 180,133 |
| Receivables | 640,302 | 606,157 | 482,325 | 367,577 | 260,881 |
| Inventories | 490,649 | 381,067 | 457,219 | 284,038 | 175,230 |
| TOTAL | $1,551,539 | $1,210,210 | $1,286,644 | $771,933 | $631,141 |
| Non-Current Assets | |||||
| PPE Net | 477,754 | 477,997 | 544,146 | 486,758 | 233,372 |
| Intangibles | 1,827,440 | 1,802,257 | 2,081,195 | 71,043 | 827,795 |
| Other Non-Current Assets | 149,300 | 175,426 | 440,751 | 12,155 | 130,710 |
| TOTAL | $2,454,494 | $2,455,680 | $3,066,092 | $569,956 | $1,191,877 |
| Total Assets | $4,006,033 | $3,665,890 | $4,352,736 | $1,341,889 | $1,823,018 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 44,228 | 21,479 | 21,449 | 89,171 | 17,719 |
| Accounts payable and accrued liabilities | 619,428 | 513,452 | 532,135 | 207,401 | 58,952 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 244,653 |
| TOTAL | $676,902 | $550,406 | $553,850 | $296,883 | $321,324 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,771,704 | 2,609,046 | 2,630,598 | 1,355,274 | 813,545 |
| Other Non-Current Liabilities | 174,783 | 339,843 | 263,241 | 21,159 | 62,127 |
| TOTAL | $2,984,199 | $2,768,696 | $2,902,523 | $1,420,588 | $877,720 |
| Total Liabilities | $3,661,101 | $3,319,102 | $3,456,373 | $1,717,471 | $1,199,044 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 299,821 | 299,226 | 298,690 | 73,936 | 73,748 |
| Common Shares | 2,997 | 2,992 | 2,987 | N/A | 739 |
| Retained earnings | -286,821 | -377,880 | -20,920 | -382,785 | 98,192 |
| Other shareholders' equity | 343 | 114,710 | 383,858 | -1,359 | -8,013 |
| TOTAL | $344,932 | $346,788 | $896,363 | $-375,582 | $623,974 |
| Total Liabilities And Equity | $4,006,033 | $3,665,890 | $4,352,736 | $1,341,889 | $1,823,018 |